Literature DB >> 20131565

Randomized controlled trial of the Breast Cancer Recovery Program for women with breast cancer-related lymphedema.

Marjorie K McClure1, Richard J McClure, Richard Day, Adam M Brufsky.   

Abstract

Evidence-based exercise and relaxation recommendations for people with breast cancer-related lymphedema (BCRL) are needed. We report a randomized controlled study of one program, designed to achieve synergistic improvements in physical and emotional BCRL symptoms. People in the treatment group received an exercise and relaxation program, The Breast Cancer Recovery Program (N=16). The control participants (N=16) continued with health professionals' recommendations. Participants were tested at entry, 2.5 weeks, 5 weeks, and 3 months. Treatment group participants, compared with control participants, demonstrated significant treatment effects for improved bioimpedance z, arm flexibility, quality of life, mood at 3 months, and weight loss. Adherence was high for this safe and effective program, which improved lymphedema physical and emotional symptoms.

Entities:  

Mesh:

Year:  2010        PMID: 20131565     DOI: 10.5014/ajot.64.1.59

Source DB:  PubMed          Journal:  Am J Occup Ther        ISSN: 0272-9490


  19 in total

1.  Randomised controlled trial to determine the benefit of daily home-based exercise in addition to self-care in the management of breast cancer-related lymphoedema: a feasibility study.

Authors:  Eunice Jeffs; Theresa Wiseman
Journal:  Support Care Cancer       Date:  2012-10-17       Impact factor: 3.603

Review 2.  Home-based multidimensional survivorship programmes for breast cancer survivors.

Authors:  Karis Kin Fong Cheng; Yee Ting Ethel Lim; Zhi Min Koh; Wilson Wai San Tam
Journal:  Cochrane Database Syst Rev       Date:  2017-08-24

Review 3.  Multidisciplinary rehabilitation for follow-up of women treated for breast cancer.

Authors:  Fary Khan; Bhasker Amatya; Louisa Ng; Marina Demetrios; Nina Y Zhang; Lynne Turner-Stokes
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 4.  Exercise interventions on health-related quality of life for cancer survivors.

Authors:  Shiraz I Mishra; Roberta W Scherer; Paula M Geigle; Debra R Berlanstein; Ozlem Topaloglu; Carolyn C Gotay; Claire Snyder
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 5.  Exercise interventions on health-related quality of life for people with cancer during active treatment.

Authors:  Shiraz I Mishra; Roberta W Scherer; Claire Snyder; Paula M Geigle; Debra R Berlanstein; Ozlem Topaloglu
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

6.  Exercise interventions for cancer survivors: a meta-analysis of quality of life outcomes.

Authors:  Rebecca A Ferrer; Tania B Huedo-Medina; Blair T Johnson; Stacey Ryan; Linda S Pescatello
Journal:  Ann Behav Med       Date:  2011-02

7.  Effect of exercise mode on physical function and quality of life in breast cancer-related lymphedema: a randomized trial.

Authors:  Maged A Basha; Nancy H Aboelnour; Ashwag S Alsharidah; FatmaAlzahraa H Kamel
Journal:  Support Care Cancer       Date:  2021-10-20       Impact factor: 3.603

8.  Active exercises utilizing a facilitating device in the treatment of lymphedema resulting from breast cancer therapy.

Authors:  Maria de Fátima Guerreiro Godoy; Antonio Helio Oliani; Jose Maria Pereira de Godoy
Journal:  Ger Med Sci       Date:  2010-11-18

Review 9.  Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes.

Authors:  Andrea L Pusic; Yeliz Cemal; Claudia Albornoz; Anne Klassen; Stefan Cano; Isabel Sulimanoff; Marisol Hernandez; Marga Massey; Peter Cordeiro; Monica Morrow; Babak Mehrara
Journal:  J Cancer Surviv       Date:  2012-12-05       Impact factor: 4.442

10.  The effect of yoga on women with secondary arm lymphoedema from breast cancer treatment.

Authors:  Annette Loudon; Tony Barnett; Neil Piller; Maarten A Immink; Denis Visentin; Andrew D Williams
Journal:  BMC Complement Altern Med       Date:  2012-05-28       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.